The effect of gout on health-related quality of life, work productivity, resource use and clinical outcomes among patients with hypertension

References

• Roubenoff R. Gout and hyperuricemia. Rheum. Dis. Clin. North Am. 16(3), 539–550 (1990).
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Bardin T et al.; EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 65(10), 1312–1324 (2006).
   PubMed Web of Science ®Google Scholar
• Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 63(10), 3136–3141 (2011).
   PubMed Web of Science ®Google Scholar
• Khanna D, Ahmed M, Yontz D et al. The disutility of chronic gout. Qual. Life Res. 17(5), 815–822 (2008).
   PubMedGoogle Scholar
• Lee SJ, Hirsch JD, Terkeltaub R et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford) 48(5), 582–586 (2009).
   PubMed Web of Science ®Google Scholar
• Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case–control study. Rheumatology (Oxford) 46(9), 1441–1444 (2007).
   PubMed Web of Science ®Google Scholar
• Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann. Rheum. Dis. 67(9), 1310–1316 (2008).
   PubMed Web of Science ®Google Scholar
• Wu EQ, Patel PA, Yu AP et al. Disease-related and all-cause health care costs of elderly patients with gout. J. Manag. Care Pharm. 14(2), 164–175 (2008).
   PubMed Web of Science ®Google Scholar
• Brook RA, Kleinman NL, Patel PA et al. The economic burden of gout on an employed population. Curr. Med. Res. Opin. 22(7), 1381–1389 (2006).
   PubMed Web of Science ®Google Scholar
• Kleinman NL, Brook RA, Patel PA et al. The impact of gout on work absence and productivity. Value in Health 10(4), 231–237 (2007).
   PubMed Web of Science ®Google Scholar
• Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res. Ther. 8(Suppl. 1), S2 (2006).
   PubMed Web of Science ®Google Scholar
• Pandya BJ, Zhu Y, Choi H. Higher comorbidities in patients with gout versus without gout in the US general population: The National Health and Nutrition Examination Survey (NHANES) 2007–2008. Value in Health 13, A302 (2010).
   Google Scholar
• Becker MA, Schumacher HR, Benjamin KL et al.; Gout Natural History Study Group. Quality of life and disability in patients with treatment-failure gout. J. Rheumatol. 36(5), 1041–1048 (2009).
   PubMed Web of Science ®Google Scholar
• Edwards NL. The role of hyperuricemia in vascular disorders. Curr. Opin. Rheumatol. 21(2), 132–137 (2009).
   PubMed Web of Science ®Google Scholar
• Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 61(7), 885–892 (2009).
   PubMed Web of Science ®Google Scholar
• Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res. (Hoboken) 62(2), 170–180 (2010).
   PubMed Web of Science ®Google Scholar
• Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual. Life Res. 18(4), 415–422 (2009).
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Wagner JS, Yuan Y, L’Italien G, Langley P, Ray Kim W. The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. J. Med. Econ. 14(2), 253–261 (2011).
   PubMedGoogle Scholar
• Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J. Occup. Environ. Med. 53(9), 1025–1029 (2011).
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kid Dis. 49, S1–S180 (2007).
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40(5), 373–383 (1987).
   PubMedGoogle Scholar
• Ware J Jr, Kosinski M, Turner-Bowker DM et al. How to Score Version 2 of the SF-12v2 Health Survey (with a supplement documenting version 1). QualityMetric Inc., RI, USA (2002).
   Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5), 353–365 (1993).
   PubMed Web of Science ®Google Scholar
• Goossens ME, Rutten-van Mölken MP, Vlaeyen JW, van der Linden SM. The cost diary: a method to measure direct and indirect costs in cost–effectiveness research. J. Clin. Epidemiol. 53(7), 688–695 (2000).
   PubMed Web of Science ®Google Scholar
• Petrou S, Murray L, Cooper P, Davidson LL. The accuracy of self-reported healthcare resource utilization in health economic studies. Int. J. Technol. Assess. Health Care 18(3), 705–710 (2002).
   PubMed Web of Science ®Google Scholar
• Pinto D, Robertson MC, Hansen P, Abbott JH. Good agreement between questionnaire and administrative databases for health care use and costs in patients with osteoarthritis. BMC Med. Res. Methodol. 11, 45 (2011).
   PubMedGoogle Scholar
• Raina P, Torrance-Rynard V, Wong M, Woodward C. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Serv. Res. 37(3), 751–774 (2002).
   PubMed Web of Science ®Google Scholar
• Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR. Self-reports of health care utilization compared to provider records. J. Clin. Epidemiol. 54(2), 136–141 (2001).
   PubMed Web of Science ®Google Scholar
• Brook RA, Forsythe A, Smeeding JE, Lawrence Edwards N. Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr. Med. Res. Opin. 26(12), 2813–2821 (2010).
   PubMed Web of Science ®Google Scholar
• Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am. J. Med. 118(8), 816–826 (2005).
   PubMed Web of Science ®Google Scholar
• Becker MA, Jolly M. Hyperuricemia and associated diseases. Rheum. Dis. Clin. North Am. 32(2), 275–93, v (2006).
   PubMed Web of Science ®Google Scholar
• Baker JF, Schumacher HR, Krishnan E. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology 58(4), 450–457 (2007).
   PubMed Web of Science ®Google Scholar